Erich Studerus
Lecturer / Researcher
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (8)
Year:
2026
Adverse childhood experiences (ACEs) are common in people at clinical high-risk for psychosis (CHR), however, the relationship between ACEs and long-term clinical outcomes is still unclear. This study examined associations between ACEs and clinical outcomes in CHR individuals. 344 CHR individuals and 67 healthy controls (HC) were assessed using the Childhood Trauma Questionnaire (CTQ), the Bullying Questionnaire and the Childhood Experience of Care and Abuse (CECA). CHR were followed up for up to 5 years. Remission from the CHR state, transition to psychosis (both defined with the Comprehensive Assessment of an At Risk Mental State), and level of functioning (assessed with the Global Assessment of Functioning) were assessed. Stepwise and multilevel logistic regression models were used to investigate the relationship between ACEs and outcomes. ACEs were significantly more prevalent in CHR individuals than in HC. Within the CHR cohort, physical abuse was associated with a reduced likelihood of remission (OR = 3.64, p = 0.025). Separation from a parent was linked to an increased likelihood of both remission (OR = 0.32, p = 0.011) and higher level of functioning (OR = 1.77, p = 0.040). Death of a parent (OR = 1.87, p = 0.037) was associated with an increased risk of transitioning to psychosis. Physical abuse and death of a parent are related to adverse long-term outcomes in CHR. The counter-intuitive association between separation from a parent and outcomes may reflect the removal of a child from an adverse environment. Future studies should investigate whether interventions targeting the effect of specific ACEs might help to improve outcomes in this population.
Year:
2025
Background The At Risk Mental State (ARMS) (also known as the Ultra or Clinical High Risk) criteria identify individuals at high risk for psychotic disorder. However, there is a need to improve prediction as only about 18% of individuals meeting these criteria develop a psychosis with 12-months. We have developed and internally validated a prediction model using characteristics that could be used in routine practice. Methods We conducted a systematic review and individual participant data meta-analysis, followed by focus groups with clinicians and service users to ensure that identified factors were suitable for routine practice. The model was developed using logistic regression with backwards selection and an individual participant dataset. Model performance was evaluated via discrimination and calibration. Bootstrap resampling was used for internal validation. Results We received data from 26 studies contributing 3739 individuals; 2909 from 20 of these studies, of whom 359 developed psychosis, were available for model building. Age, functioning, disorders of thought content, perceptual abnormalities, disorganised speech, antipsychotic medication, cognitive behavioural therapy, depression and negative symptoms were associated with transition to psychosis. The final prediction model included disorders of thought content, disorganised speech and functioning. Discrimination of 0.68 (0.5-1 scale; 1=perfect discrimination) and calibration of 0.91 (0-1 scale; 1=perfect calibration) showed the model had fairly good predictive ability. Discussion The statistically robust prediction model, built using the largest dataset in the field to date, could be used to guide frequency of monitoring and enable rational use of health resources following assessment of external validity and clinical utility.
Year:
2025
Importance Inflammation is increasingly implicated in the pathophysiology of mood and psychotic disorders. Integrating blood biomarkers and brain imaging may help uncover mechanistic pathways and guide targeted interventions. Objective To identify shared and distinct multivariate patterns of peripheral inflammation and gray matter volume (GMV) in early-stage depressive and psychotic disorders using a transdiagnostic machine learning approach. Design, Setting, and Participants The naturalistic multicenter PRONIA study was conducted between February 2014 and May 2019 with a follow-up period of up to 36 months; baseline data were analyzed between August 2021 and April 2024. Eight sites, including inpatient and outpatient facilities, in 5 European countries (Germany, Italy, Switzerland, Finland, and the United Kingdom) were included. The study included individuals with recent-onset depression (ROD, n = 163) or psychosis (ROP, n = 177) or clinical high-risk states for psychosis (CHR-P, n = 172), all with minimal medication exposure, and healthy control (HC) individuals (n = 166). Exposures Structural magnetic resonance imaging (MRI), peripheral assays of cytokines (eg, interleukin [IL] 6, IL-1β, tumor necrosis factor [TNF] α, C-reactive protein [CRP], brain-derived neurotrophic factor [BDNF], S100 calcium-binding protein B [S100B]); clinical assessments; neurocognitive testing. Main Outcomes and Measures After data collection, sparse partial least squares was used to identify latent brain-blood signatures. Support vector machine classification evaluated psychosocial and neurocognitive predictors of signature expression using repeated nested cross-validation. Results A total of 678 participants (346 [51.0%] female; median [IQR] age, 24.0 [20.9-28.9] years) were included. Four signatures were identified. A psychosis signature (ρ = 0.27; P = .002) differentiated ROP from CHR-P with elevated IL-6, TNF-α, and reduced CRP, alongside GMV shifts in corticothalamic circuits. A depression signature (ρ = 0.19; P = .02) differentiated ROD from HC individuals with elevated IL-1β, IL-2, IL-4, S100B, and BDNF and GMV reductions in limbic regions. Additional signatures reflected age (ρ = 0.67) and sex or MRI quality (ρ = 0.53). Psychosocial features, including a differential childhood trauma pattern, predicted both the psychosis (balanced accuracy [BAC] = 67.2%) and depression (BAC = 78.0%) signatures. Cognitive performance predicted only the psychosis signature (BAC = 65.1%). Conclusions and Relevance In this study, early-stage depression and psychosis exhibited distinct neurobiological signatures involving immune and neuroanatomical markers, challenging fully dimensional disease models. These signatures are shaped by childhood trauma and cognition and may support biologically informed early interventions.
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2021
Collaborators (26)
Ryan Hammoud
King’s College London
Mirabel Pelton
Research Associate
University of Cambridge
Dr Sian Lowri Griffiths
Assistant Professor
University of Birmingham
Lucia Valmaggia
Professor of Clinical Psychology in Youth Mental Health
King’s College London
Stephan Ruhrmann
Lecturer
University of Cologne
Pablo A Gaspar
Profesor Asociado
Universidad de Chile
Paris Alexandros Lalousis
Lecturer in Artificial Intelligence in Mental Health
King’s College London
Giampaolo Perna
Professore Ordinario di Psichiatria
Humanitas University
Chantal Michel
Head psychologist
University Hospital of Psychiatry and Psychotherapy
Rachel Upthegrove
Professor of Psychiatry
University of Birmingham
Stefan Borgwardt
Chair
University of Lübeck
Gemma Modinos
Professor of Neuroscience & Mental Health
King’s College London
Catrin Tudur Smith
Personal Chair
University of Liverpool
Tim Ziermans
Academic, Assistant Professor
University of Amsterdam
Maude Schneider
Associate Professor
Université de Genève
Ana Catalan
Professor
King's College London Institute of Psychiatry Psychology and Neuroscience
David Popovic
Max Planck Institute of Psychiatry
Mark van der Gaag
University of Amsterdam
Sophie Parker
Professor of Youth Mental Health
The University of Manchester
Anja Richter
King’s College London
Anita Riecher-Rössler
University of Basel
Suk Kyoon An
Yonsei University College of Medicine
Peter J. Uhlhaas
-
Laura Bonnett
Reader
University of Liverpool
Henri Pesonen
Assistant Professor
University of Tampere
Roberta Passiatore
Researcher
University of California, Irvine
Make your next move.
Prepare your application
Review drafts before you send them.